ConocoPhillips (NYSE:COP) and its partners struck oil with a second exploration well offshore West Africa in the Sangomar Deep block, the company said Monday. ConocoPhillips (NYSE:COP) belongs to Basic Materials sector. Its net profit margin is 17.20% and weekly performance is 1.47%. On last trading day company shares ended up $71.60. ConocoPhillips (NYSE:COP) distance from 50-day simple moving average (SMA50) is -3.37%. On Nov 02, Publicis Groupe SA is in talks to buy Sapient Corp. (NASDAQ:SAPE) as the French advertising giant seeks to speed up its transformation into a digital-technology company and bounce back from its failed attempt to merge with Omnicom Group Inc. Sapient Corp. (NASDAQ:SAPE) shares fell -0.08% in last trading session and ended the day at $24.65. SAPE Gross Margin is 30.50% and its return on assets is 12.20%. Sapient Corp. (NASDAQ:SAPE) quarterly performance is 68.14%. PTC Inc (NASDAQ:PTC) reported results for its fourth fiscal quarter ended September 30, 2014. Non-GAAP revenue of $368 million, up 7% over Q4’13 non-GAAP revenue and up 6% on a constant currency basis. Non-GAAP EPS of $0.67, up 13% year over year and up 12% year over year on a constant currency basis On 10 November, PTC Inc. (NASDAQ:PTC) shares remains unchanged and was closed at $37.07. PTC EPS growth in last 5 year was 37.80%. PTC Inc. (NASDAQ:PTC) year to date (YTD) performance is 4.75%. On Oct. 30, Neustar, Inc. (NYSE:NSR), announced results for the quarter ended September 30, 2014, and updated its guidance for 2014. Revenue totaled $243.9 million, a 7% increase from $227.6 million in 2013. Marketing Services revenue of $37.5 million grew 21% driven by higher demand for the company's workflow solutions. NeuStar, Inc. (NYSE:NSR) ended the last trading day at $26.62. Company weekly volatility is calculated as 1.86% and price to cash ratio as 5.98. NeuStar, Inc. (NYSE:NSR) showed a weekly performance of 0.30%. On Nov 06, EDAP TMS SA (NASDAQ:EDAP) received a letter from the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) on its current PMA application for Ablatherm Integrated Imaging Device. The FDA letter stated that while EDAP's Ablatherm-HIFU PMA is not approvable in its current form, it provides specific guidance and recommendations as to a path forward. EDAP TMS SA (NASDAQ:EDAP) shares increased 4.81% in last trading session and ended the day at $1.71. EDAP Gross Margin is 40.10% and its return on assets is -18.50%. EDAP TMS SA (NASDAQ:EDAP) quarterly performance is 14.77%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
